"We don't get a lot of things to really care about." So, you think you are interested in science, eh? Well, let's see how the sausage is made. Today we share our experience generating the FSHD-like minipig models, which will be key tools for testing and advancing better FSHD therapeutics and developing methods for building back your muscles. --- Send in a voice message: https://podcasters.spotify.com/pod/show/peter-l-jones/message

"Come out to the coast, we'll get together, have a few laughs..." The holiday season we discuss the recent FDA approved CRISPR therapy for sickle cell disease and some dynamics of methylation. --- Send in a voice message: https://podcasters.spotify.com/pod/show/peter-l-jones/message

"As I leave my competition respirator style, climb the ladder to success escalator style." Today we have the Jaegercast, but first we continue our discussion about apabetalone, a new candidate drug for FSHD. --- Send in a voice message: https://podcasters.spotify.com/pod/show/peter-l-jones/message

"I don't know how I'm going to live with myself if I don't stay true to what I believe." We evaluate the recent published work describing apabetalone, a small molecule drug from Resverlogix Corp that has been around for awhile and in clinic for other indications and is now being assessed more seriously as a potential therapeutic for FSHD. Overall, while lacking in some areas, this initial study is generally positive and supports that it is a new candidate worthy of further evaluation. ---...

"I am sick and tired of the entire western world knowing how my kidneys are functioning!" We discuss current and upcoming FSHD clinical trials and touch a little bit on funding. --- Send in a voice message: https://podcasters.spotify.com/pod/show/peter-l-jones/message

"Farmer Hoggett knew that little ideas that tickled, and nagged, and refused to go away should never be ignored, for in them lie the seeds of destiny." We are in Australia promoting FSHD awareness with Parliament and to gather government support for FSHD diagnostics and clinical trial infrastructure, as well as catching up with many of our Australian friends. --- Send in a voice message: https://podcasters.spotify.com/pod/show/peter-l-jones/message

"Life has meaning only in the struggle. Triumph or defeat is in the hands of God. So let us celebrate the struggle!" With the FDA approval of the first gene therapy for DMD and clinical trials for FSHD in all stages of planning and performance, we take a moment to discuss the history of the DMD gene therapy path to approval as it relates to FSHD and address the important, yet oft ignored, concept of Therapeutic Misconception. --- Send in a voice message:...

"It's human nature to lie. Most of the time we can't even be honest with ourselves." At MyFSHD is is always FSHD Day. We continue the conversation around therapeutic modalities and clinical trials, hopefully providing additional context for clarification, or just digging a deeper hole. You tell us. --- Send in a voice message: https://podcasters.spotify.com/pod/show/peter-l-jones/message

"Apes don't read philosophy." "Yes they do, Otto, they just don't understand it!" We're here to answer your questions and help you understand all things (FSHD) on your mind. --- Send in a voice message: https://podcasters.spotify.com/pod/show/peter-l-jones/message

"We can rebuild him. We have the technology. We can make him better than he was. Better, stronger, faster." Today we are at the Biologic Scaffolds for Regenerative Medicine Symposium to discuss novel ways to potentially help FSHDers maintain strength and slow down pathology. Additional technology being presented by be applicable to help regain muscle mass after therapy. Joining us is one of the best FSHD advocates around, Emma Weatherley from FSHD Global Research Foundation in Australia. And...

"We Are Unique, Gentlemen, In That We Create Ourselves Through Long Years Of Rigorous Training, Sacrifice, Denial, Pain." Today we focus on our worldwide efforts to help FSHDers everywhere. --- Send in a voice message: https://podcasters.spotify.com/pod/show/peter-l-jones/message

Roy: "This is everything, ain't it? This is the choice it comes down to - this is our immortality." Romeo: "You don't need to be thinking immortality - you need to be thinking hit the 7 iron!" Dr Charis Himeda joins us to discuss recent news on stem cells, losmapimod, gene therapy, and antisense for FSHD. --- Send in a voice message: https://podcasters.spotify.com/pod/show/peter-l-jones/message

"You just put your pickle on everybody's plate, college boy, and leave the hard stuff to me." We talk a little more about funding, hopefully providing some clarity, then bring on our Angry Dad for some questions, and then bring it home with another new track from Jaeger. --- Send in a voice message: https://podcasters.spotify.com/pod/show/peter-l-jones/message

"Sorry, Vern. I guess a more experienced shopper could have gotten more for your seven cents."  Rare disease day is the last day of February, which got us thinking about what really needs to be done to get over the line.  We also answer listener questions about animal models and the Avidity, myostatin inhibition, and cell therapy trials. --- Send in a voice message: https://podcasters.spotify.com/pod/show/peter-l-jones/message

"Come on in, grab a beer.  Don't cost nothing."  We have been podcasting about all things FSHD and realize that we have a lot of new listeners over the past year so we want to take this opportunity to catch everyone up on what the MyFSHD podcast is all about.  You may have noticed that we are a bit different.  We are not asking for money and we are not selling you anything, just real talk from experts in all things FSHD to help you understand and navigate the space with knowledge.  On the...

"Why, sometimes I've believed as many as six impossible things before breakfast."  Experimental therapies designed specifically for FSHD are finally arriving for trial in the clinic (i.e., in people).  Today we discuss the upcoming Phase 1/2 clinical trial from Avidity using their antibody oligo conjugated siRNA designed specifically to knockdown the DUX4 mRNA in FSHD. --- Send in a voice message: https://anchor.fm/peter-l-jones/message

"Come on in, grab a beer.  Don't cost nothin'."  As season 2 of the MyFSHD podcast gets rolling, we take time to bring our new listeners up to speed.  We are about real information on FSHD diagnostics, therapeutics, research, foundations, really anything FSHD.  We are 100% volunteers, we don't raise money and we are here to serve you, the worldwide FSHD community. --- Send in a voice message: https://anchor.fm/peter-l-jones/message

"Do you ever have déjà vu, Mrs. Lancaster?"  "I don't think so, but I could check with the kitchen"  We will discuss some cool new pig data and how we are going about making sure our FSHD-like minipig models will be made right and properly characterized to be useful for testing FSHD therapeutics and muscle building strategies.  As you know, the devil is always in the details and so far pigs are looking pretty darn good! --- Send in a voice message: https://anchor.fm/peter-l-jones/message

"I've been going to this high school for 7-1/2 years.  I'm no dummy."  As 2023 gets underway, let's check in and see where the field stands - in our opinion, of course. --- Send in a voice message: https://anchor.fm/peter-l-jones/message

"Life isn't like in the movies.  Life..... is much harder."  Whatever you end up doing, love it.  And we love working every day on the problem of FSHD, educating others about the science, helping people learn about themselves, and informing the community of advancements.  We're back and going strong, starting Season 2 with a discussion on the future of clinical trials and therapies, as requested by you. --- Send in a voice message: https://anchor.fm/peter-l-jones/message

"Remember no man is a failure who has friends." We catch up with a few friends in this holiday season as FSHD research plows ahead. --- Send in a voice message: https://anchor.fm/peter-l-jones/message

"I want four fried chickens and a Coke".  Dr. Charis Himeda joins us as we discuss some encouraging recent data from Sarepta for one of their DMD gene therapy trials and from Avidity for their myotonic dystrophy phase I/II trial and how it all potentially impacts FSHD.  In addition, we revisit the potential (or lack there of) for placental or umbilical cord derived stem cell therapy for FSHD. --- Send in a voice message: https://anchor.fm/peter-l-jones/message

"Never mind manoeuvres, always go at them". Dr. Bob Bloch from the University of Maryland School of Medicine joins us to discuss his development of the human FSHD muscle xenograft mouse model that is a key tool in the pre-clinical testing pipeline for FSHD therapeutics and biomarker discovery. --- Send in a voice message: https://anchor.fm/peter-l-jones/message

"You're messing with the wrong guy!"  Happy Thanksgiving to our friends in the US, and for everyone else, it is always a good time to remember and give thanks for those you care about and who care about you.  For us, that is the worldwide FSHD community.  Today we have Brad, our angry dad, and discuss accessibility issues for safety and dealing with roadblocks in research. --- Send in a voice message: https://anchor.fm/peter-l-jones/message